Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 199

1.
2.

Yes, We Still Need IL-2 Receptor Antagonists.

Fleming JN, Taber DJ, Pilch NA, Srinivas TR, Chavin KD.

Am J Transplant. 2016 Nov;16(11):3308-3309. doi: 10.1111/ajt.13930. No abstract available.

PMID:
27321737
3.

Incidence and risk factors of hepatocellular carcinoma after orthotopic liver transplantation.

Colhoun ED 5th, Forsberg CG, Chavin KD, Baliga PK, Taber DJ.

Surgery. 2016 Oct 19. pii: S0039-6060(16)30484-6. doi: 10.1016/j.surg.2016.08.049. [Epub ahead of print]

PMID:
27771158
4.

Twenty years of evolving trends in racial disparities for adult kidney transplant recipients.

Taber DJ, Gebregziabher M, Hunt KJ, Srinivas T, Chavin KD, Baliga PK, Egede LE.

Kidney Int. 2016 Oct;90(4):878-87. doi: 10.1016/j.kint.2016.06.029.

PMID:
27555121
5.

Depression, Resource Utilization, and Outcomes Following Liver Transplant.

Sebaaly JC, Fleming J, Pilch N, Meadows H, Finn A, Chavin K, Baliga P, Bratton CF, McGillicuddy JW, Nadig S, Taber D.

Prog Transplant. 2016 Sep;26(3):270-6. doi: 10.1177/1526924816654641.

PMID:
27297232
6.

Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching.

Rohan VS, Taber DJ, Moussa O, Pilch NA, Denmark S, Meadows HB, McGillicuddy JW, Chavin KD, Baliga PK, Bratton CF.

Exp Clin Transplant. 2016 Jun 3. doi: 10.6002/ect.2015.0274. [Epub ahead of print]

7.

Predicting and preventing readmissions in kidney transplant recipients.

Covert KL, Fleming JN, Staino C, Casale JP, Boyle KM, Pilch NA, Meadows HB, Mardis CR, McGillicuddy JW, Nadig S, Bratton CF, Chavin KD, Baliga PK, Taber DJ.

Clin Transplant. 2016 Jul;30(7):779-86. doi: 10.1111/ctr.12748.

PMID:
27101090
8.

A patient navigator and education program for increasing potential living donors: a comparative observational study.

Marlow NM, Kazley AS, Chavin KD, Simpson KN, Balliet W, Baliga PK.

Clin Transplant. 2016 May;30(5):619-27. doi: 10.1111/ctr.12728.

PMID:
26928471
9.

A randomized, prospective comparison of transition to sirolimus-based CNI-minimization or withdrawal in African American kidney transplant recipients.

Fleming JN, Taber DJ, Pilch NA, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD, Bratton CF.

Clin Transplant. 2016 May;30(5):528-33. doi: 10.1111/ctr.12718.

PMID:
26914542
10.

Dietary Saturated Fat Promotes Development of Hepatic Inflammation Through Toll-Like Receptor 4 in Mice.

Sutter AG, Palanisamy AP, Lench JH, Esckilsen S, Geng T, Lewin DN, Cowart LA, Chavin KD.

J Cell Biochem. 2016 Jul;117(7):1613-21. doi: 10.1002/jcb.25453.

PMID:
26600310
11.

Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients.

Jordan CL, Taber DJ, Kyle MO, Connelly J, Pilch NW, Fleming J, Meadows HB, Bratton CF, Nadig SN, McGillicuddy JW, Chavin KD, Baliga PK, Shatat IF, Twombley K.

Pediatr Transplant. 2016 Feb;20(1):44-8. doi: 10.1111/petr.12625.

PMID:
26576516
12.

SphK1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes.

Geng T, Sutter A, Harland MD, Law BA, Ross JS, Lewin D, Palanisamy A, Russo SB, Chavin KD, Cowart LA.

J Lipid Res. 2015 Dec;56(12):2359-71. doi: 10.1194/jlr.M063511.

13.

Racial disparity outcomes in patients undergoing hepatectomy: is baseline kidney function a potential explanation?

Palanisamy AP, Dowden JE, Al Manasra AR, Rohan VS, Bratton CF, McGillicuddy JW, Baliga PK, Chavin KD, Taber DJ.

Prog Transplant. 2015 Sep;25(3):257-62. doi: 10.7182/pit2015765.

PMID:
26308786
14.

Sustainability of improvements in medication adherence through a mobile health intervention.

McGillicuddy JW, Taber DJ, Mueller M, Patel S, Baliga PK, Chavin KD, Sox L, Favela AP, Brunner-Jackson BM, Treiber FA.

Prog Transplant. 2015 Sep;25(3):217-23. doi: 10.7182/pit2015975.

PMID:
26308780
15.

Patient-Centered mHealth Living Donor Transplant Education Program for African Americans: Development and Analysis.

Sieverdes JC, Nemeth LS, Magwood GS, Baliga PK, Chavin KD, Brunner-Jackson B, Patel SK, Ruggiero KJ, Treiber FA.

JMIR Res Protoc. 2015 Aug 10;4(3):e84. doi: 10.2196/resprot.3715.

16.

Development of steatohepatitis in Ob/Ob mice is dependent on Toll-like receptor 4.

Sutter AG, Palanisamy AP, Lench JH, Jessmore AP, Chavin KD.

Ann Hepatol. 2015 Sep-Oct;14(5):735-43.

17.

Equalizing MELD Scores Over Broad Geographies Is Not the Most Efficacious Way to Allocate a Scarce Resource in a Value-based Environment.

Reed A, Chapman WC, Knechtle S, Chavin K, Gilroy R, Klintmalm GB.

Ann Surg. 2015 Aug;262(2):220-3. doi: 10.1097/SLA.0000000000001331. No abstract available.

PMID:
26164428
18.

Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study.

Fischer L, Saliba F, Kaiser GM, De Carlis L, Metselaar HJ, De Simone P, Duvoux C, Nevens F, Fung JJ, Dong G, Rauer B, Junge G; H2304 Study Group..

Transplantation. 2015 Jul;99(7):1455-62. doi: 10.1097/TP.0000000000000555.

PMID:
26151607
19.

African American kidney transplant patients' perspectives on challenges in the living donation process.

Sieverdes JC, Nemeth LS, Magwood GS, Baliga PK, Chavin KD, Ruggiero KJ, Treiber FA.

Prog Transplant. 2015 Jun;25(2):164-75. doi: 10.7182/pit2015852.

20.

African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients.

Taber DJ, Gebregziabher MG, Srinivas TR, Chavin KD, Baliga PK, Egede LE.

Pharmacotherapy. 2015 Jun;35(6):569-77. doi: 10.1002/phar.1591.

Items per page

Supplemental Content

Loading ...
Support Center